Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Post Herpetic Neuralgia

An Infectious Disease Case Study

Read the Case Study

About the Case Study

To successfully complete a Phase II Post Herpetic Neuralgia (PHN) study, Pharm-Olam was contracted to provide a full-service solution to support 103 patients from 27 sites in four countries. In the past, study sponsors have had difficulty recruiting patients in Post Herpetic Neuralgia studies, but due to prior experience with these studies and a proactive approach, Pharm-Olam recruited the required number of patients seven weeks prior to the sponsors’ deadline.

Study Overview:

  • Phase: II
  • Patients: 103
  • Sites: 27 in 4 countries - South Africa, Bulgaria, Georgia, and Ukraine
  • Services Provided: Regulatory, Monitoring, Project Management, Medical Writing, Data Management, Statistics, Pharmacovigilance, Medical Monitoring, DSMB Management


 

How can we help you create a healthier world?

Talk to one of our experts today.

Please choose one.

Contact Us